Literature DB >> 1647074

Sequence requirements for activation of the HIV-1 LTR by human cytomegalovirus.

B J Biegalke1, A P Geballe.   

Abstract

Human cytomegalovirus (CMV) alters the growth and expression of human immunodeficiency virus-1 (HIV-1) in cell culture and may accelerate the course of AIDS in HIV-1 infected patients. CMV infection or the expression of the CMV immediate early genes has been shown to activate gene expression directed by the HIV-1 LTR. However, the cis-acting elements within the HIV-1 LTR that confer responsiveness to CMV have not been clearly delineated. We report on investigations in human fibroblasts designed to precisely map this signal. Our studies demonstrate that more than one nonoverlapping region of the HIV-1 promoter is capable of responding to CMV. Sequences 3' from -19(relative to the start of transcription) are dispensable for CMV responsiveness. We also show that in addition to immediate early region 2, immediate early region 1 is able to activate HIV-1 LTR-directed gene expression.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1647074     DOI: 10.1016/0042-6822(91)90151-z

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  39 in total

1.  Human cytomegalovirus IE2 86-kilodalton protein binds p53 but does not abrogate G1 checkpoint function.

Authors:  L R Bonin; J K McDougall
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Variable inhibition of cell-free translation by HIV-1 transcript leader sequences.

Authors:  A P Geballe; M K Gray
Journal:  Nucleic Acids Res       Date:  1992-08-25       Impact factor: 16.971

3.  The human cytomegalovirus 80-kilodalton but not the 72-kilodalton immediate-early protein transactivates heterologous promoters in a TATA box-dependent mechanism and interacts directly with TFIID.

Authors:  C Hagemeier; S Walker; R Caswell; T Kouzarides; J Sinclair
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

4.  Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene.

Authors:  J Kimpton; M Emerman
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

5.  TAF-like functions of human cytomegalovirus immediate-early proteins.

Authors:  D M Lukac; N Y Harel; N Tanese; J C Alwine
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

6.  IE2 protein is insufficient for transcriptional repression of the human cytomegalovirus US3 promoter.

Authors:  B J Biegalke
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

7.  Transcriptional activation by the human cytomegalovirus immediate-early proteins: requirements for simple promoter structures and interactions with multiple components of the transcription complex.

Authors:  D M Lukac; J R Manuppello; J C Alwine
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

8.  Characterization of the transcriptional repressive element of the human cytomegalovirus immediate-early US3 gene.

Authors:  B J Biegalke
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Identification and characterization of a human herpesvirus 6 gene segment capable of transactivating the human immunodeficiency virus type 1 long terminal repeat in an Sp1 binding site-dependent manner.

Authors:  J Wang; C Jones; M Norcross; E Bohnlein; A Razzaque
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

10.  Identification of binding sites for the 86-kilodalton IE2 protein of human cytomegalovirus within an IE2-responsive viral early promoter.

Authors:  H Arlt; D Lang; S Gebert; T Stamminger
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.